News
Indian Pharma Exports Rose By 8% In The Q1 To $6.26 Billion
Indian pharmaceutical exports increased by 8% in the first quarter of the current fiscal year to $6.26 billion, with officials anticipating a 10% increase by year's end.
Pharma exports to the European Union and other CIS countries, which were affected...
Drug Research
GenKOre- Korea Creating Base-Editing Tech For Genetic Issues
Adenine base editors were successfully created by GenKOre, a biotech startup in South Korea, using its unique hypercompact gene-editing method.
The hypercompact ABEs created by GenKOre are distinguished by their small size, ability to be delivered via an adeno-associated virus...
IT & Data Management
Regulators Agree To Work Together On The Unification of RWE
Real-world evidence (RWE) should be included in regulatory decision-making, according to a declaration backed by both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). The International Coalition of Medicines Regulatory Authorities (ICMRA) released a...
Drug Research
Brazil, India, SA Scientists Seek Speedier Antibiotic Nod
According to a paper examining the present environment for antimicrobial development in Brazil, India, and South Africa, lowering regulatory barriers to hasten the clearance of novel antibiotics will aid in the development and accessibility of those drugs.
Given that antibiotics...
Drug Research
Serum Institute Wins USFDA Approval To Export Novavax Jab
The FDA has given the go-ahead to the Serum Institute of India (SII) to eventually supply a COVID-19 vaccine to the U.S. with Novavax's Nuvaxovid.
The emergency use authorization granted to Novavax's recombinant protein-based vaccination on July 13th means SII...
Clinical Trials
NIH Conducts Clinical Trial of The mRNA Nipah Virus Jab
An early-stage clinical trial assessing an investigational vaccine to stave off Nipah virus infection has been started by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health. Produced by Moderna, Inc....
Drug Research
Genomic Studies Utilize Scale As Clinical Utility Catches Up
An innovative system for monitoring chromosomal fragility and copy number alterations in particularly lethal tumours was described earlier this July by researchers from Cambridge University and the National Cancer Research Center in Madrid. Researchers believe this is the first time...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read